Stille AB – FDA 483, Sep 28, 2023

An FDA inspection of Stille AB, a medical device manufacturer in Torshalla, Sweden, identified two significant observations. The firm's procedures for handling and investigating complaints were found to be inadequate, with several complaint investigations lacking proper documentation. Additionally, procedures for the acceptance of incoming critical components were not adequately established, as packing slips failed to document acceptance activity results.